The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise!
World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy!
Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval
Nature Medicine publishes results of H-drug combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma
NYU Langone Hospitals
Genkore Announces Collaboration With Us Company On In Vivo Gene Editing Therapies
